NPI registry status
Active
2026 NPPES data Dermatopathology Physician NPI 1467462929 MD
Verify on CMS → Lady Dy, MD
Dermatopathology Physician in Glenview, Illinois.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 570 in Dermatopathology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 367 beneficiaries · Dermatopathology Physician avg: 650
Generic prescribing
98%
generic claims · 2% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
97.3/100
▲ 14 pts above national avg 83.1 · Exceptional
Industry payments
$41.3K
60 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Lady Dy, MD reported a CMS MIPS final score of 97.3/100 - above the 83.1 national average - and filed 1,263 Medicare Part D claims in 2023.
- 97.3/100
- MIPS score · +14 vs avg
- 1K
- Part D claims, 2023
- 98%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Lady Dy, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
97 Top 15% higher than 85% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Lady Dy, MD sits
This provider among dermatopathology physician peers
Across the 210 dermatopathology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Lady Dy, MD writes more Part D claims than 84% of them and scores higher on MIPS quality than 74% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one dermatopathology physician peer from a representative sample of 60; the gold marker is Lady Dy, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Lady Dy, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Lady Dy, MD?
High performer (top quartile)Primary specialty
Dermatopathology Physician
Medicare Part D claims
1,263 94% vs specialty avg
MIPS final score
97.3/100 14.2 pts vs avg
Specialty distribution in Illinois
How Dermatopathology Physician compares to other specialties among Illinois providers
Medicare quality performance, MIPS
Lady Dy, MD's 2023 MIPS final score plotted against the Dermatopathology Physician national average
- MIPS Final Score
- 97.3/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Dermatopathology Physician) - 97.3/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Lady Dy, MD appears in the CMS NPPES registry as a Dermatopathology Physician provider holding MD credentials at 1452 WAUKEGAN RD, Glenview, IL, 60025, with a listed phone of (847) 832-1185. NPI 1467462929 was issued on 08/08/2006.
Medicare Part D records for calendar year 2023 show 1,263 prescription claims written by this provider, covering 367 Medicare beneficiaries and totaling roughly $39K in drug spend, split 2% brand-name and 98% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 97.3/100 for the 2023 performance year (Quality 95), compared with the national average of 83.1.
Dermatopathology Physician is a narrow specialty nationwide, with 570 enrolled providers across 48 states and an average of 650 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1467462929 |
|---|---|
| Specialty | Dermatopathology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 08/08/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
97.25
Final Score
Avg: 83.1
95
Quality
100
Promoting Interoperability
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Lady Dy, MD. Source: openpaymentsdata.cms.gov.
Total received
$41.3K
Largest payer
Lilly USA, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Illinois IDFPR 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 - they are NOT specific to Lady Dy, MD. To verify Lady Dy, MD's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases
IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Lady Dy, MD - brand share 2.0%
Dermatopathology Physician average
2% brand-name claims vs 98% generic, on 1,263 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,263
Total Claims
$39K
Total Drug Cost
367
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,619
- Total Day Supply
- 75,765
- Brand vs Generic
- 2% brand / 98% generic
- Brand Drug Cost
- $4K
- Generic Drug Cost
- $35K
- Antibiotic Claims
- 88
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 0.84
- Gender Split
- 87% female / 13% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Lady Dy, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Finasteride
Finasteride
375 claims
- Minoxidil
Minoxidil
288 claims
- Betamethasone Dipr… 84
Betamethasone Dipropionate
84 claims
- Doxycycline Hyclate 66
Doxycycline Hyclate
66 claims
- Dutasteride 47
Dutasteride
47 claims
- Clobetasol Propion… 40
Clobetasol Propionate
40 claims
- Ketoconazole 31
Ketoconazole
31 claims
- Hydroxychloroquine… 30
Hydroxychloroquine Sulfate
30 claims
| Drug | Claims |
|---|---|
| Finasteride | 375 |
| Minoxidil | 288 |
| Betamethasone Dipropionate | 84 |
| Doxycycline Hyclate | 66 |
| Dutasteride | 47 |
| Clobetasol Propionate | 40 |
| Ketoconazole | 31 |
| Hydroxychloroquine Sulfate | 30 |
| Triamcinolone Acetonide | 29 |
| Mometasone Furoate | 28 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatopathology Physician Overview
How Lady Dy, MD fits within the Dermatopathology Physician landscape nationally.
570
Dermatopathology Physician Providers in US
48
States with Dermatopathology Physician
650
Avg Claims per Provider
Lady Dy, MD's 1,263 claims are above the specialty average of 650.
Nearby Dermatopathology Physician Providers in Illinois
Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as Dy.
Dr. Motunrayo Adisa
M.D
Kenilworth, IL
Dr. Debra Bakal
M.D.
Hoffman Estates, IL
Dr. Justin Bandino
MD
Scott Air Force Base, IL
Dr. Janeen Buonaccorsi
M.D.
Peoria, IL
Dr. Jordan Carqueville
MD
Chicago, IL
Compare Dermatopathology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Illinois medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Dermatopathology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Illinois
Frequently Asked Questions
What is Lady Dy, MD's specialty? ▼
Lady Dy, MD specializes in Dermatopathology Physician and practices in Glenview, Illinois. Credentials: MD.
How much does Lady Dy, MD prescribe under Medicare Part D? ▼
In 2023, Lady Dy, MD wrote 1,263 Medicare Part D claims totaling $39K in drug costs for 367 beneficiaries.
What is Lady Dy, MD's Medicare quality score? ▼
Lady Dy, MD has a CMS MIPS Final Score of 97.3/100 (Quality: 95). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Lady Dy, MD located? ▼
Lady Dy, MD is located at 1452 WAUKEGAN RD, Glenview, IL, 60025. Phone: (847) 832-1185.
What is Lady Dy, MD's NPI number? ▼
Lady Dy, MD's National Provider Identifier (NPI) is 1467462929, issued on 08/08/2006.
Does Lady Dy, MD prescribe more brand-name or generic drugs? ▼
Lady Dy, MD's prescribing is 2% brand-name and 98% generic drugs by claim count, with $4K in brand drug costs.
How many Dermatopathology Physician providers are there in the US? ▼
There are 570 Dermatopathology Physician providers across 48 states in the US. The average Dermatopathology Physician provider writes 650 Medicare Part D claims per year.
What drugs does Lady Dy, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Lady Dy, MD's most frequently prescribed drugs include Finasteride, Minoxidil, Betamethasone Dipropionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Lady Dy, MD accept Medicare? ▼
Lady Dy, MD appears in CMS Medicare data with 1,263 Part D claims and 367 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Lady Dy, MD's credentials? ▼
Lady Dy, MD's NPI is 1467462929 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.